Update on enthesitis-related arthritis

Area of Science:

• Pediatric Rheumatology
• Immunogenetics
• Disease Pathogenesis

Background:

• Enthesitis-related arthritis (ERA) is a significant pediatric rheumatic condition.
• Understanding ERA's genetic and pathogenic underpinnings is crucial for effective management.

Purpose of the Study:

• To provide a comprehensive update on genetics, pathogenesis, phenotype evaluation, therapies, and outcomes in pediatric ERA.
• To synthesize recent findings and identify future research directions.

Main Methods:

• Review of recent literature on ERA genetics (e.g., HLA-B27, TLR4, NLRP3).
• Analysis of studies on ERA pathogenesis, including microbiome and γδ-T cell roles.
• Evaluation of imaging techniques (ultrasonography, MRI) for phenotype assessment.
• Assessment of current and emerging therapeutic strategies, including biologics.

Main Results:

• Recent genetic studies explore HLA-B27 subtypes and non-MHC genes.
• Investigational areas include the microbiome, γδ-T cells, and advanced imaging.
• Randomized controlled trials and long-term effectiveness studies of biologics have advanced treatment understanding.

Conclusions:

• Significant progress has been made in understanding ERA genetics, pathogenesis, and treatment.
• Further research is needed on the microbiome, IL-17/IL-23 axis, and novel therapies in this pediatric population.